scholarly journals Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients

2016 ◽  
Vol 71 (9) ◽  
pp. 2651-2653 ◽  
Author(s):  
L. Bocket ◽  
G. Peytavin ◽  
E. K. Alidjinou ◽  
F. Ajana ◽  
P. Choisy ◽  
...  
2015 ◽  
Vol 31 (5) ◽  
pp. 475-478 ◽  
Author(s):  
Cathia Soulie ◽  
Gilles Peytavin ◽  
Charlotte Charpentier ◽  
Sidonie Lambert-Niclot ◽  
Sophie Sayon ◽  
...  

2009 ◽  
Vol 54 (1) ◽  
pp. 72-77 ◽  
Author(s):  
Anne-Genevieve Marcelin ◽  
Philippe Flandre ◽  
Diane Descamps ◽  
Laurence Morand-Joubert ◽  
Charlotte Charpentier ◽  
...  

ABSTRACT To identify factors associated with virological response (VR) to an etravirine (ETR)-based regimen, 243 patients previously treated with nonnucleoside reverse transcriptase inhibitors (NNRTIs) were studied. The impact of baseline HIV-1 RNA, CD4 cell count, past NNRTIs used, 57 NNRTI resistance mutations, genotypic sensitivity score (GSS) for nucleoside reverse transcriptase inhibitors (NRTIs) and protease inhibitors (PIs), and the number of new drugs used with ETR for the first time on the VR to an ETR regimen were investigated. Among the 243 patients, the median baseline HIV-1 RNA level was 4.4 log10 copies/ml (interquartile range [IQR], 3.7 to 4.9) and the median CD4 count was 175 cells/mm3 (IQR, 69 to 312). Patients had been previously exposed to a median of 6 NRTIs, 1, NNRTI, and 5 PIs. Overall, 82% of patients achieved a VR at month 2, as defined by a decrease of at least 1.5 log10 copies/ml and/or HIV-1 RNA level of <50 copies/ml. No difference in VR was observed between patients receiving or not a boosted PI in combination with ETR. Factors independently associated with a better VR to ETR were the number of drugs (among enfuvirtide, darunavir, or raltegravir) used for the first time in combination with ETR and the presence of the K103N mutation at baseline. Mutations Y181V and E138A were independently associated with poor VR, whereas no effect of the Y181C on VR was observed. In conclusion, ETR was associated with high response rates in NNRTI-experienced patients in combination with other active drugs regardless of the therapeutic class used.


2013 ◽  
Vol 42 (1) ◽  
pp. 42-47 ◽  
Author(s):  
Anne-Geneviève Marcelin ◽  
Constance Delaugerre ◽  
Céline Beaudoux ◽  
Diane Descamps ◽  
Laurence Morand-Joubert ◽  
...  

2007 ◽  
Vol 1 (1) ◽  
Author(s):  
Massimo Fabiani ◽  
Barbara Nattabi ◽  
Chiara Pierotti ◽  
Filippo Ciantia ◽  
Alex A Opio ◽  
...  
Keyword(s):  

AIDS ◽  
2002 ◽  
Vol 16 (14) ◽  
pp. 1867-1876 ◽  
Author(s):  
Andrea Antinori ◽  
Maria Letizia Giancola ◽  
Susanna Grisetti ◽  
Fabio Soldani ◽  
Lucia Alba ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Benjamin S. Naovarat ◽  
Marka A. Lyons ◽  
Jonathan D. Dau ◽  
Binh Y. Nguyen ◽  
Gloria A. Salazar ◽  
...  

2014 ◽  
Vol 67 (2) ◽  
pp. 153-160 ◽  
Author(s):  
Lu Zheng ◽  
Babafemi Taiwo ◽  
Rajesh T. Gandhi ◽  
Peter W. Hunt ◽  
Ann C. Collier ◽  
...  

2011 ◽  
Vol 204 (8) ◽  
pp. 1211-1216 ◽  
Author(s):  
Sidonie Lambert-Niclot ◽  
Philippe Flandre ◽  
Marc-Antoine Valantin ◽  
Gilles Peytavin ◽  
Claudine Duvivier ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document